Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001816518-21-000001
Filing Date
2021-02-03
Accepted
2021-02-03 17:23:41
Documents
1
Effectiveness Date
2021-02-03
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 7489
  Complete submission text file 0001816518-21-000001.txt   8638
Mailing Address 230 PARK AVENUE, SUITE 2800 NEW YORK NY 10169
Business Address 230 PARK AVENUE, SUITE 2800 NEW YORK NY 10169 781-367-5419
Nine Square Therapeutics Corp (Filer) CIK: 0001816518 (see all company filings)

EIN.: 850634503 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-370079 | Film No.: 21587383